--- title: "SNDL Inc. (SNDL.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/SNDL.US.md" symbol: "SNDL.US" name: "SNDL Inc." industry: "Pharmaceuticals" datetime: "2026-05-20T06:07:03.492Z" locales: - [en](https://longbridge.com/en/quote/SNDL.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/SNDL.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/SNDL.US.md) --- # SNDL Inc. (SNDL.US) ## Company Overview SNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally. It operates through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. The company engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sale of wines, beers, and spirits through liquor stores under the Wine and Beyond, Ace Liquor, and Liquor Depot retail banners; and private sale of adult-use cannabis products and accessories through its corporate-owned, controlled, and franchised retail cannabis stores. | Item | Detail | |------|--------| | Industry | Pharmaceuticals | | Exchange | US Market | | Website | [www.sndl.com](https://www.sndl.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: C > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-19T04:30:13.000Z **Overall: C (0.46)** **Industry**: Pharmaceuticals | Metric | Value | |--------|-------| | Industry Ranking | 81 / 190 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: C #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 2.30% | | | Net Profit YoY | 89.61% | | | P/B Ratio | 0.46 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 361817000.00 | | | Revenue | 679779252.04 | | #### Multi Score Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -1.00% | D | | Profit Margin | -1.17% | D | | Gross Margin | 26.96% | C | | Revenue YoY | 2.30% | C | | Net Profit YoY | 89.61% | A | | Total Assets YoY | 2.96% | C | | Net Assets YoY | 1.59% | C | | Cash Flow Margin | -606.76% | E | | OCF YoY | 2.30% | C | | Turnover | 0.71 | B | | Gearing Ratio | 17.27% | A | ```chart-data:radar { "title": "Longbridge Financial Score - SNDL Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "2.30%", "rating": "" }, { "name": "Net Profit YoY", "value": "89.61%", "rating": "" }, { "name": "P/B Ratio", "value": "0.46", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "361817000.00", "rating": "" }, { "name": "Revenue", "value": "679779252.04", "rating": "" } ] }, { "name": "Multi Score", "grade": "C", "indicators": [ { "name": "ROE", "value": "-1.00%", "rating": "D" }, { "name": "Profit Margin", "value": "-1.17%", "rating": "D" }, { "name": "Gross Margin", "value": "26.96%", "rating": "C" }, { "name": "Revenue YoY", "value": "2.30%", "rating": "C" }, { "name": "Net Profit YoY", "value": "89.61%", "rating": "A" }, { "name": "Total Assets YoY", "value": "2.96%", "rating": "C" }, { "name": "Net Assets YoY", "value": "1.59%", "rating": "C" }, { "name": "Cash Flow Margin", "value": "-606.76%", "rating": "E" }, { "name": "OCF YoY", "value": "2.30%", "rating": "C" }, { "name": "Turnover", "value": "0.71", "rating": "B" }, { "name": "Gearing Ratio", "value": "17.27%", "rating": "A" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -45.12 | 220/190 | - | - | - | | PB | 0.46 | 17/190 | 0.70 | 0.52 | 0.45 | | PS (TTM) | 0.53 | 19/190 | 0.82 | 0.61 | 0.52 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Cormedix (CRMD.US) | A | A | B | C | B | A | | 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B | | 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B | | 04 | Roche (RHHBY.US) | A | B | B | D | B | B | | 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-04-30T04:00:00.000Z Total Analysts: **2** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 50% | | Overweight | 1 | 50% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 1.38 | | Highest Target | 4.97 | | Lowest Target | 3.50 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SNDL.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SNDL.US/norm.md) - [Related News](https://longbridge.com/en/quote/SNDL.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SNDL.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**